Literature DB >> 9009807

Autonomic patterns during respiratory suspensions: possible markers of Transcendental Consciousness.

F Travis1, R K Wallace.   

Abstract

In two experiments, we investigated physiological correlates of transcendental consciousness during Transcendental Meditation sessions. In the first, experimenter-initiated bells, based on observed physiological patterns, marked three phases during a Transcendental Meditation session in 16 individuals. Interrater reliability between participant and experimenter classification of experiences at each bell was quite good. During phases including transcendental consciousness experiences, skin conductance responses and heart rate deceleration occurred at the onset of respiratory suspensions or reductions in breath volume. In the second experiment, this autonomic pattern was compared with that during forced breath holding. Phasic autonomic activity was significantly higher at respiratory suspension onset than at breath holding onset. These easily measured markers could help focus research on the existence and characteristics of transcendental consciousness.

Entities:  

Mesh:

Year:  1997        PMID: 9009807     DOI: 10.1111/j.1469-8986.1997.tb02414.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  13 in total

Review 1.  Review of controlled research on the transcendental meditation program and cardiovascular disease. Risk factors, morbidity, and mortality.

Authors:  Kenneth G Walton; Robert H Schneider; Sanford Nidich
Journal:  Cardiol Rev       Date:  2004 Sep-Oct       Impact factor: 2.644

Review 2.  [Does meditation improve the quality of life for patients living with cancer?].

Authors:  Pascal Lamanque; Serge Daneault
Journal:  Can Fam Physician       Date:  2006-04       Impact factor: 3.275

3.  The Center for Brain, Consciousness, and Cognition at Maharishi University of Management.

Authors:  Fred Travis
Journal:  Cogn Process       Date:  2010-02

4.  A self-referential default brain state: patterns of coherence, power, and eLORETA sources during eyes-closed rest and Transcendental Meditation practice.

Authors:  Fred Travis; David A F Haaga; John Hagelin; Melissa Tanner; Alaric Arenander; Sanford Nidich; Carolyn Gaylord-King; Sarina Grosswald; Maxwell Rainforth; Robert H Schneider
Journal:  Cogn Process       Date:  2009-10-28

5.  Changes in autonomic variables following two meditative states described in yoga texts.

Authors:  Shirley Telles; Bhat Ramachandra Raghavendra; Kalkuni Visweswaraiah Naveen; Nandi Krishnamurthy Manjunath; Sanjay Kumar; Pailoor Subramanya
Journal:  J Altern Complement Med       Date:  2012-09-04       Impact factor: 2.579

6.  A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year.

Authors:  Robert H Schneider; Charles N Alexander; Frank Staggers; David W Orme-Johnson; Maxwell Rainforth; John W Salerno; William Sheppard; Amparo Castillo-Richmond; Vernon A Barnes; Sanford I Nidich
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

7.  Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2012-08

8.  Acute effects of transcendental meditation on hemodynamic functioning in middle-aged adults.

Authors:  V A Barnes; F A Treiber; J R Turner; H Davis; W B Strong
Journal:  Psychosom Med       Date:  1999 Jul-Aug       Impact factor: 4.312

9.  Psychosocial stress and cardiovascular disease. Part 3: Clinical and policy implications of research on the transcendental meditation program.

Authors:  Kenneth G Walton; Robert H Schneider; John W Salerno; Sanford I Nidich
Journal:  Behav Med       Date:  2005       Impact factor: 3.879

10.  Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans.

Authors:  A Castillo-Richmond; R H Schneider; C N Alexander; R Cook; H Myers; S Nidich; C Haney; M Rainforth; J Salerno
Journal:  Stroke       Date:  2000-03       Impact factor: 10.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.